Sponsored by

Cleveland Clinic Brain Tumor and Neuro-Oncology Center

Please click on the above banner for more details

WEBSITECHANGES

You can Subscribe to our RSS FEED: which delivers brain tumor news and additions to the website via RSS.

Click HERE for details on RSS.

Displaying items 1001 to 1025 of about 5880

Previous 25

Website Changes

11/18/2019

Extensive brainstem infiltration, not mass effect, is a common feature of end-stage cerebral glioblastomas.

11/18/2019

Another paid survey!

11/13/2019

Clinical Efficacy of Weekly ONC201 in Adult Recurrent Glioblastoma Published

10/27/2019

Musella Foundation Online Support Groups are moving!

10/26/2019

NYU Langone Health launches new molecular assay to identify patients with brain tumors

10/24/2019

GBM patient and Caregiver Survey

10/22/2019

Donate or request expensive medicines!

10/10/2019

Oncology Pioneer xCures Names Experts to Advisory Boards

10/10/2019

New Trial of Focused Ultrasound in Glioblastoma: Opening the Blood-Brain Barrier for Chemotherapy

10/10/2019

First-line treatment of ONC 201 in newly diagnosed DIPG pediatric patients is now open.

10/09/2019

Any Amazon users?

09/30/2019

Optune Open House

09/27/2019

Barriers to accrual and enrollment in brain tumor trials

09/25/2019

Medicenna Presents Promising Update from its MDNA55 Clinical Trial in Recurrent Glioblastoma at the Targeting Innate Immunity Congress

09/14/2019

DeAngelis named MSK physician-in-chief, chief medical officer

09/13/2019

Tocagen Reports Results of Toca 5 Phase 3 Trial in Recurrent Brain Cancer

09/11/2019

Frankly Speaking About Brain Tumors

09/11/2019

Publication Reports Clinical Efficacy of ONC201 in Expanded Access H3 K27M-mutant Glioma Patients

09/09/2019

Bristol-Myers Squibb`s Opdivo fails 3rd straight test in tough-to-treat brain cancer

09/09/2019

Novocure Announces 27 Presentations at the American Society for Radiation Oncology 2019 Annual Meeting

08/30/2019

Musella Foundation awards a pediatric brain tumor research grant!

08/15/2019

DelMar Pharmaceuticals Reports Updated Results on Twenty Patients from the Phase 2 Clinical Trial of VAL-083 as First-Line Treatment in Newly-Diagnosed MGMT-Unmethylated Glioblastoma MultiForme (GBM)

08/15/2019

Attend an Optune Open House

08/03/2019

Validation of an effective implantable pump-infusion system for chronic convection-enhanced delivery of intracerebral topotecan in a large animal model.

08/03/2019

Young adults diagnosed with high grade gliomas: Patterns of care, outcomes, and impact on employment.

Our privacy / cookie policy has changed.
Click HERE to read it!